A newly published study in the Journal of Clinical Microbiology puts concrete data behind a long recognized problem in Lyme disease care.
The research, supported by the Bay Area Lyme Foundation and based on data from the Lyme Disease Biobank, found that FDA-cleared testing methods miss between 64 and 78 percent of early Lyme cases.
This includes patients who present with the classic erythema migrans (EM) rash that is widely considered a key indicator of early infection.
This highlights the need for improved diagnostics for Lyme disease.
Source:
https://www.lymedisease.org/standard-lyme-tests-miss-most/ (opens in new tab) and Bay Area Lyme Foundation.
Lymedisease.org is one of many respected patient-run physician finders that allow fast and easy access to useful physicians.